Functional repair of human donor lungs by IL-10 gene therapy

Science Translational Medicine

Volumn 1, Issue 4, 2009, Pages

  Cypel, Marcelo ^a,b   Liu, Mingyao ^a,b   Rubacha, Matt ^a   Yeung, Jonathan C ^a,b   Hirayama, Shin ^a,b   Anraku, Masaki ^a,b   Sato, Masaaki ^a,b   Medin, Jeffrey ^c   Davidson, Beverly L ^d   De Perrot, Marc ^a,b   Waddell, Thomas K ^a,b   Slutsky, Arthur S ^e,f   Keshavjee, Shaf ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d UNIVERSITY OF IOWA   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL; ANIMAL MODEL; ARTICLE; GENE THERAPY; GENETICS; HUMAN; INFLAMMATION; LUNG; LUNG TRANSPLANTATION; PATHOPHYSIOLOGY; SWINE; TIGHT JUNCTION; TRANSPLANTATION;

ANIMALS; GENE THERAPY; HUMANS; INFLAMMATION; INTERLEUKIN-10; LUNG; LUNG TRANSPLANTATION; MODELS, ANIMAL; SWINE; TIGHT JUNCTIONS; TISSUE AND ORGAN PROCUREMENT;

EID: 77952001279     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000266     Document Type: Article

References (49)

1. J. D. Punch, D. H. Hayes, F. B. LaPorte, V. McBride, M. S. Seely, Organ donation and utilization in the United States, 1996-2005. Am. J. Transplant. 7, 1327-1338 (2007).
2. M. de Perrot, M. Liu, T. K. Waddell, S. Keshavjee, Ischemia-reperfusion- induced lung injury. Am. J. Respir. Crit. Care Med. 167, 490-511 (2003).
3. S. M. Kawut, A. Reyentovich, J. S. Wilt, R. Anzeck, D. J. Lederer, M. K. O'Shea, J. R. Sonett, S. M. Arcasoy, Outcomes of extended donor lung recipients after lung transplantation. Transplantation 79, 310-316 (2005).
4. J. De Meester, J. M. Smits, G. G. Persijn, A. Haverich, Listing for lung transplantation: Life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J. Heart Lung Transplant. 20, 518-524 (2001).
5. L. B. Ware, Y. Wang, X. Fang, M. Warnock, T. Sakuma, T. S. Hall, M. Matthay, Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 360, 619-620 (2002).
6. A. J. Fisher, S. C. Donnelly, N. Hirani, C. Haslett, R. M. Strieter, J. H. Dark, P. A. Corris, Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation. Am. J. Respir. Crit. Care Med. 163, 259-265 (2001).
7. H. Kaneda, T. K. Waddell, M. de Perrot, X. H. Bai, C. Gutierrez, T. Arenovich, C. Chaparro, M. Liu, S. Keshavjee, Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am. J. Transplant. 6, 544-551 (2006).
8. D. J. Moore, J. F. Markmann, S. Deng, Avenues for immunomodulation and graft protection by gene therapy in transplantation. Transpl. Int. 19, 435-445 (2006).
9. K. W. Moore, R. de Waal Malefyt, R. L. Coffman, A. O'Garra, Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19, 683-765 (2001).
10. S. Fischer, M. Liu, A. A. MacLean, M. de Perrot, M. Ho, J. A. Cardella, X. M. Zhang, X. H. Bai, M. Suga, Y. Imai, S. Keshavjee, In vivo transtracheal adenovirus-mediated transfer of human interleukin-10 gene to donor lungs ameliorates ischemia-reperfusion injury and improves early posttransplant graft function in the rat. Hum. Gene Ther. 12, 1513-1526 (2001).
11. S. Martins, M. de Perrot, Y. Imai, M. Yamane, S. M. Quadri, L. Segall, A. Dutly, S. Sakiyama, A. Chaparro, B. L. Davidson, T. K. Waddell, M. Liu, S. Keshavjee, Transbronchial administration of adenoviral-mediated interleukin-10 gene to the donor improves function in a pig lung transplant model. Gene Ther. 11, 1786-1796 (2004).
12. S. Fischer, M. de Perrot, M. Liu, A. A. MacLean, J. A. Cardella, Y. Imai, M. Suga, S. Keshavjee, Interleukin 10 gene transfection of donor lungs ameliorates posttransplant cell death by a switch from cellular necrosis to apoptosis. J. Thorac. Cardiovasc. Surg. 126, 1174-1180 (2003).
13. H. Itano, W. Zhang, J. H. Ritter, T. J. McCarthy, T. Mohanakumar, G. A. Patterson, Adenovirusmediated gene transfer of human interleukin 10 ameliorates reperfusion injury of rat lung isografts. J. Thorac. Cardiovasc. Surg. 120, 947-956 (2000).
14. C. Pellegrini, T. O'Brien, A. Jeppsson, L. A. Fitzpatrick, J. Yap, H. D. Tazelaar, C. G. McGregor, Influence of temperature on adenovirus-mediated gene transfer. Eur. J. Cardiothorac. Surg. 13, 599-603 (1998).
15. S. D. Cassivi, J. A. Cardella, S. Fischer, M. Liu, A. S. Slutsky, S. Keshavjee, Transtracheal gene transfection of donor lungs prior to organ procurement increases transgene levels at reperfusion and following transplantation. J. Heart Lung Transplant. 18, 1181-1188 (1999).
16. A. Chapelier, C. Danel, M. Mazmanian, E. A. Bacha, H. Sellak, M. A. Gilbert, P. Hervé, P. Lemarchand, Gene therapy in lung transplantation: Feasibility of ex vivo adenovirus-mediated gene transfer to the graft. Hum. Gene Ther. 7, 1837-1845 (1996).
17. M. Cypel, J. C. Yeung, S. Hirayama, M. Rubacha, S. Fischer, M. Anraku, M. Sato, S. Harwood, A. Pierre, T. K. Waddell, M. de Perrot, M. Liu, S. Keshavjee, Technique for prolonged normothermic ex vivo lung perfusion. J. Heart Lung Transplant. 27, 1319-1325 (2008).
18. A. K. Sharma, L. G. Fernandez, A. S. Awad, I. L. Kron, V. E. Laubach, Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-α during pulmonary ischemia-reperfusion injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L105-L113 (2007).
19. J. B. Orens, A. Boehler, M. de Perrot, M. Estenne, A. R. Glanville, S. Keshavjee, R. Kotloff, J. Morton, S. M. Studer, D. Van Raemdonck, T. Waddel, G. I. Snell; Pulmonary Council, International Society for Heart and Lung Transplantation, A review of lung transplant donor acceptability criteria. J. Heart Lung Transplant. 22, 1183-1200 (2003).
20. C. B. Coyne, M. K. Vanhook, T. M. Gambling, J. L. Carson, R. C. Boucher, L. G. Johnson, Regulation of airway tight junctions by proinflammatory cytokines. Mol. Biol. Cell 13, 3218-3234 (2002).
21. A. Youakim, M. Ahdieh, Interferon-g decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am. J. Physiol. 276, G1279-G1288 (1999).
22. E. Mazzon, D. Puzzolo, A. P. Caputi, S. Cuzzocrea, Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis. Mol. Med. 8, 353-366 (2002).
23. J. D. Christie, M. Carby, R. Bag, P. Corris, M. Hertz, D. Weill; ISHLT Working Group on Primary Lung Graft Dysfunction, Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 24, 1454-1459 (2005).
24. J. D. Christie, J. S. Sager, S. E. Kimmel, V. N. Ahya, C. Gaughan, N. P. Blumenthal, R. M. Kotloff, Impact of primary graft failure on outcomes following lung transplantation. Chest 127, 161-165 (2005).
25. C. M. Burton, M. Iversen, N. Milman, M. Zemtsovski, J. Carlsen, D. Steinbrüchel, J. Mortensen, C. B. Andersen, Outcome of lung transplanted patients with primary graft dysfunction. Eur. J. Cardiothorac. Surg. 31, 75-82 (2007).
26. J. D. Christie, R.M. Kotloff, A. Pochettino, S. M.Arcasoy, B. R. Rosengard, J. R. Landis, S. E. Kimmel, Clinical risk factors for primary graft failure following lung transplantation. Chest 124, 1232-1241 (2003).
27. J. C. Lee, J. D. Christie, Primary graft dysfunction. Proc. Am. Thorac. Soc. 6, 39-46 (2009).
28. V. S. Avlonitis, C. H. Wigfield, J. A. Kirby, J. H. Dark, The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am. J. Transplant. 5, 684-693 (2005).
29. W. Y. Park, R. B. Goodman, K. P. Steinberg, J. T. Ruzinski, F. Radella II, D. R. Park, J. Pugin, S. J. Skerrett, L. D. Hudson, T. R. Martin, Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 164, 1896-1903 (2001).
30. L. Armstrong, A. B. Millar, Relative production of tumour necrosis factor a and interleukin 10 in adult respiratory distress syndrome. Thorax 52, 442-446 (1997).
31. R. D. Huhn, E. Radwanski, S. M. O'Connell, M. G. Sturgill, L. Clarke, R. P. Cody, M. B. Affrime, D. L. Cutler, Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 87, 699-705 (1996).
32. C. Volpers, S. Kochanek, Adenoviral vectors for gene transfer and therapy. J. Gene Med. 6, S164-S171 (2004).
33. T. Shirakawa, Clinical trial design for adenoviral gene therapy products. Drug News Perspect. 22, 140-145 (2009).
34. R. de Waal Malefyt, J. Abrams, B. Bennett, C. G. Figdor, J. E. de Vries, Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220 (1991).
35. D. F. Fiorentino, M. W. Bond, T. R. Mosmann, Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170, 2081-2095 (1989).
36. A. Carrel, C. A. Lindbergh, The culture of whole organs. Science 81, 621-623 (1935).
37. W. Wisser, D. Oturanlar, R. Minich, H. Ringl, T. Wekerle, W. Klepetko, E. Wolner, Closed circuit perfusion of an isolated rabbit lung. A new model for the evaluation of preservation quality of stored lungs. Eur. J. Cardiothorac. Surg. 7, 71-74 (1993).
38. L. S. Wang, K. Yoshikawa, S. Miyoshi, K. Nakamoto, C. M. Hsieh, F. Yamazaki, P. F. Guerreiro Cardoso, H. J. Schaefers, J. Brito, S. H. Keshavjee, The effect of ischemic time and temperature on lung preservation in a simple ex vivo rabbit model used for functional assessment. J. Thorac. Cardiovasc. Surg . 98, 333-342 (1989).
39. S. Steen, Q. Liao, P. N. Wierup, R. Bolys, L. Pierre, T. Sjöberg, Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. Ann. Thorac. Surg. 76, 244-252 (2003).
40. S. Steen, T. Sjöberg, L. Pierre, Q. Liao, L. Eriksson, L. Algotsson, Transplantation of lungs from a non-heart-beating donor. Lancet 357, 825-829 (2001).
41. M. de Perrot, S. Fischer, M. Liu, Y. Imai, S. Martins, S. Sakiyama, T. Tabata, X. H. Bai, T. K. Waddell, B. L. Davidson, S. Keshavjee, Impact of human interleukin-10 on vector-induced inflammation and early graft function in rat lung transplantation. Am. J. Respir. Cell Mol. Biol. 28, 616-625 (2003).
42. M. Cypel, H. Kaneda, M. Anraku, J. Yeung, M. DePerrot, A. Pierre, T. K. Waddell, M. Liu, S. Keshavjee, Increased levels of interleukin-1 b in clinically rejected donor lungs. J. Heart Lung Transplant. 28, S70 (2009).
43. A. S. Fanning, B. J. Jameson, L. A. Jesaitis, J. M. Anderson, The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J. Biol. Chem. 273, 29745-29753 (1998).
44. M. G. Farquhar, G. E. Palade, Junctional complexes in various epithelia. J. Cell Biol. 17, 375-412 (1963).
45. K. Kawkitinarong, L. Linz-McGillem, K. G. Birukov, J. G. Garcia, Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Am. J. Respir. Cell Mol. Biol. 31, 517-527 (2004).
46. S. M. Dudek, J. G. Garcia, Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91, 1487-1500 (2001).
47. Y. Gon, M. R. Wood, W. B. Kiosses, E. Jo, M. G. Sanna, J. Chun, H. Rosen, S1P3 receptorinduced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc. Natl. Acad. Sci. U.S.A. 102, 9270-9275 (2005).
48. R. M. Al-Sadi, T. Y. Ma, IL-1b causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 178, 4641-4649 (2007).
49. J. B. Orens, A. Boehler, M. de Perrot, M. Estenne, A. R. Glanville, S. Keshavjee, R. Kotloff, J. Morton, S. M. Studer, D. Van Raemdonck, T. Waddel, G. I. Snell; Pulmonary Council, International Society for Heart and Lung Transplantation, A review of lung transplant donor acceptability criteria. J. Heart Lung Transplant. 22, 1183-1200 (2003).